Application of antisense oligo DNA to uterine cancers.
Application of antisense oligo DNA to uterine cancers.
批准号:
05557073
负责人:
WAKE Norio
金额:
$5.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Uterine cervical cancer is the most common genital malignancy, and a strong association with human papillomaviruses (HPV) has been suggested. Only part of the HPV genome, encoding the E6 and E7 proteins, is consistently retained and expressed in Cancer cells. One important function of the E6 protein is its ability to form a complex with the cellular p53 protein, resulting in an ubiguitin-dependent degradation of the letter. Likewise, the E7 oncoprotein also forms a complex with the cell-encoded Rb protein. In the present study, first of all, we tried to confirm the association of cervical cancer with HPV infection. HPV DNA sequences were present in 43 out of 47 primary cervical cancers (91.5%). One of these cancers contained a p53 gene mutation. In addition, One of the remaining four HPV-negative cancers also contained a p53 mutation. As a result, p53 inactivation either by E6 or p53 gene mutations corresponded to the development of 44 primary cervical cancers (93.6%). We obtained both … More primary and recurrent tumors from 4 cases. In two of these cases, the HPV genomes that were present in an episomal state in the primary tumors were observed to have disappeared in the recurrent tumors. One of these recurrent tumors also contained a p53 gene mutation, which suggested the possibility that p53 inactivation was required in order to maintain the aggressive behavior this cancer either by an HPV infection or by a p53 gene umtation.Antisense oligodeoynucleotides (oligomers) have a critical role for dregs targeted specifically against oncogene. The importance of HPV E6 and E7 has been identified to include the cervical cancer and maintain its phenotype. Thus, we tried to obtain evidence for the inhibitory effects of antisense oligomers to the E6/E7 region of HPV16 on transformed cervical epithelial cell lines. The oligomers greatly reduced both cell numbers and H^3-Thymidine uptake in PHK16 and C4II cells. This potent antiproliferative activity accompanied the suppression of target gene expression. In contrast, the effects on SiHa cells were less remarkable. These inhibitory effects were not accompanied any noticeable inhibition of E7 protein synthesis. Thus, we design more efficient antisense molecules by binding the psolaren that is a strong DNA adduct, to the oligomors. The psolaren-conjugated oligomers showed the strong inhibitory effects on SiHa cells. The psolaren conjugation was able to lessen the concentration into 1/40, that showed the similar degree of growth inhibition, compared to the 20muM phospborothioate oligomers. However, the psolaren conjugated oligomers did not show any inhibitory effect on growth of the normal human epidermal karatinocytes. Less
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Arima, T: "Malignant trophoblastic neoplasms with different modes of origin." Cancer Genet Cytogenet. 85. 5-15 (1995)
Arima, T:“具有不同起源模式的恶性滋养细胞肿瘤。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Honda,et al.,: "Involvement of p53 gene mutation in human endometrial carcinomas." International Journal of Cancer.53. 963-967 (1993)
T.Honda 等人:“p53 基因突变与人类子宫内膜癌的关系。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Sasaki: "Evidence for multiple pathways to cellular senescence." Cancer Research. 54. 6090-6093 (1994)
M.Sasaki:“细胞衰老的多种途径的证据。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishida,M.,: "Transcriptional Repression of Smooth Muscle α-Actin Gene Associated with Human Papillomavirus Type 16 E7 Expression." Molecular Carcinogenesis.,. 13. 157-165 (1995)
Nishida, M.,:“与人乳头瘤病毒 16 型 E7 表达相关的平滑肌 α-肌动蛋白基因的转录抑制。”,13. 157-165 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada,H.,: "Suppression of endmetraial carcinoma cell tumorigenicity by human chromosome 18." Genes,Chromosomes and Cancer. 13. 18-24 (1995)
Yamada, H.,:“人类 18 号染色体抑制子宫内膜癌细胞致瘤性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Genome diversity associated with in montalization and establishment of endometrial cancer stem cell isolation
-
批准号:20390435
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2008
-
负责人:WAKE Norio
-
依托单位:
Molecular targeted therapy by inducing cancer cell senesence
-
批准号:14104014
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$72.47万
-
财政年份:2002
-
负责人:WAKE Norio
-
依托单位:
Molecular mechanism of endometrial carcinoma development and their application for the new molecular target therapy
-
批准号:12470344
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.5万
-
财政年份:2000
-
负责人:WAKE Norio
-
依托单位:
Molecular mechanism of cell senescence
-
批准号:11557121
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:WAKE Norio
-
依托单位:
Molecular mechanism of endometrial cancer and its application to gene diagnosis
-
批准号:09470362
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.86万
-
财政年份:1997
-
负责人:WAKE Norio
-
依托单位:
Development of new therapy for uterine cervical carcinoma
-
批准号:08557092
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$5.76万
-
财政年份:1996
-
负责人:WAKE Norio
-
依托单位:
Establishment of gene diagnosis and therapy for Endometrial carcinoma.
-
批准号:07457391
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.67万
-
财政年份:1995
-
负责人:WAKE Norio
-
依托单位:
Genetic Events Associated With Choriocarcinogenesis.
-
批准号:07042006
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.99万
-
财政年份:1995
-
负责人:WAKE Norio
-
依托单位:
Development of gene diagnosis and therapy for endometrial cancers.
-
批准号:05454453
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.16万
-
财政年份:1993
-
负责人:WAKE Norio
-
依托单位:
Genetic events associated with human endometrial carcinogenesis.
-
批准号:03454399
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1991
-
负责人:WAKE Norio
-
依托单位:
Identification of a Chromosome Carrying a Putative Tumor Suppressor gene in Human Choriocarcinoma by Microcell-Mediated Chromosome Transfer.
-
批准号:63480363
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.2万
-
财政年份:1988
-
负责人:WAKE Norio
-
依托单位:
Transformation mechanism of human choriocarcinoma
-
批准号:60570763
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1985
-
负责人:WAKE Norio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基 于多 价结 合的 自动 化核 酸提 取 方法 用于 HPV E6/E7
mRNA 的实时荧光定量 PCR 检测研究
-
批准号:2024JJ9149
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:罗磊
-
依托单位:
受HPV E6/E7调控的新lncRNA CRL通过减弱铁死亡抑制宫颈上皮内瘤变进展的机制研究
-
批准号:82301838
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:石灿
-
依托单位:
RNAm5C修饰调控HPV病毒致癌蛋白E6、E7促进宫颈癌进展的机制研究
-
批准号:32300460
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王玲芳
-
依托单位:
HPV癌蛋白E6及E7通过靶向STING的稳定性及转运抑制cGAS-STING信号通路的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:张魏芳
-
依托单位:
16型人乳头瘤状病毒(HPV16)早期基因E6/E7剪接调控与肿瘤发生的分子机制
-
批准号:82072287
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:吴成君
-
依托单位:
16型人乳头瘤状病毒(HPV16)早期基因E6/E7剪接调控与肿瘤发生的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:55万元
-
批准年份:2020
-
负责人:吴成君
-
依托单位:
HPV E6/E7通过RNA甲基转移酶METTL3调控长链非编码RNA lnc-CCDST的m6A修饰介导宫颈癌发病的分子机制研究
-
批准号:81902639
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:丁祥亚
-
依托单位:
HPV E6/E7癌蛋白与细胞增殖相关信号通路基因甲基化特征在宫颈癌风险评估中的应用
-
批准号:81973136
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陈汶
-
依托单位:
HPV E6/E7癌基因依赖性外泌体对宫颈癌细胞淋巴结转移的促进作用
-
批准号:2018JJ3316
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:李乐赛
-
依托单位:
HPV16 E6/E7介导HIF-1α上调肺癌细胞GLUT1表达的分子机制
-
批准号:81672082
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2016
-
负责人:吴广平
-
依托单位: